Loading clinical trials...
Loading clinical trials...
A Phase II Study of the Impact of Clinicogenetic Risk-Stratified Management on Outcomes of Acute Myeloid Leukemia in Older Patients
Conditions
Interventions
Cytarabine
Decitabine
+8 more
Locations
1
United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
Start Date
July 7, 2017
Primary Completion Date
March 16, 2024
Completion Date
October 1, 2024
Last Updated
March 10, 2026
NCT03874052
NCT06928662
NCT05584761
NCT04284787
NCT02835222
NCT04269213
Lead Sponsor
University of Nebraska
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions